Logo image
Sign in
A randomized double-blind phase II evaluation of the cyclooxygenase-2 protein inhibitor celecoxib in treating severe dysplasia of the cervix
Journal article   Peer reviewed

A randomized double-blind phase II evaluation of the cyclooxygenase-2 protein inhibitor celecoxib in treating severe dysplasia of the cervix

J. H. Farley, V. Truong, J. McBroom, E. Goo and W. Larsen
Journal of clinical oncology, Vol.23(16_suppl), pp.5106-5106
06/2005

Abstract

Abstract only

Metrics

1 Record Views

Details